FDA warns of faulty results with blood sugar tests

Comments:  | Leave A Comment

WASHINGTON–The Food and Drug Administration is warning diabetes patients that certain blood sugar tests can give inaccurate results in patients taking other medications.

WASHINGTON–The Food and Drug Administration is warning diabetes patients that certain blood sugar tests can give inaccurate results in patients taking other medications.

Public health regulators told consumers on Friday not to use certain glucose testing strips from Roche, Abbott Laboratories and other companies in combination with dialysis and other biologic drugs.

According to FDA, those formulations contain non-glucose sugars, which can falsely elevate blood sugar results and increase the risk of insulin overdose.

People with the disease often have to inject insulin, which helps break down carbohydrates, because their bodies have become resistant to the protein.

Dialysis and so-called immunoglobulins are most often taken by patients with serious medical ailments, including kidney failure and rheumatoid arthritis.

The biologic drugs’ labeling already warns that they can interfere with glucose monitoring tests, but FDA says the products continue to be used together despite past warnings.

______

To read the rest of this article, subscribe to our digital or paper edition. For previous editions, contact us for details.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Tags:

Comments

blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 321 other followers